<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>Gynecological Cancer News Articles Provided by Cancer Compass</title>
    <description>CancerCompass is dedicated to provided you with the most up to date cancer information and news. Visit our website to find all our articles on Gynecological Cancer News</description>
    <link>http://www.cancercompass.com/gynecological-cancer-news.htm</link>
    <pubDate>Sat, 21 Nov 2009 00:00:00 GMT</pubDate>
    <lastBuildDate>Sat, 21 Nov 2009 00:00:00 GMT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>UK Professor Helps Develop Test To Detect Ovarian Cancer</title>
      <description>After four years of research, a new test will  help identify cancer in women with ovarian cysts  before surgery. Until the OVA1 blood test was  created, a precise diagnosis before surgery  wasn't possible, said Dr. Frederick R. Ueland,  associate professor of gynecologic oncology at  the University of Kentucky College of Medicine  and a principal investigator on the research  project.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32437.htm</link>
      <author>CancerCompass</author>
      <pubDate>Thu, 19 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Lifestyle Could Reduce Cancer Two-Thirds</title>
      <description>U.S. health experts say about two-thirds of  cancers could be prevented via lifestyle  changes. The Mayo Clinic researchers explain in  their Special Report on Cancer Prevention in the  November issue of Mayo Clinic Women's  HealthSource says maintaining proper weight by  eating a healthy, low-fat diet and by stepping  up moderate to vigorous physical activity to 45  to 60 minutes almost daily might reduce one- third of cancer deaths.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32421.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 17 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Medical Patients Drawn To Internet When Managing Own Health</title>
      <description>When the pain in her knee from an old running  injury continued even after surgery, Sarah  McCluan turned to the Internet for help. I don't  use it to diagnose ,but I do go to the Internet  for basic information," said McCluan, who  downloaded some knee strengthening exercises  that she is following. McCluan, 37, of Hopewell  is among a growing number of wired adults  searching the Internet for medical information.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32422.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 17 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Leukemia Med May Also Fight Ovarian Cancer</title>
      <description>U.S. medical scientists say they've discovered  the drug Sprycel, approved for chronic myeloid  leukemia, also is effective against ovarian  cancer cells.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32405.htm</link>
      <author>CancerCompass</author>
      <pubDate>Sat, 14 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Guided Therapeutics Non-Invasive Cervical Cancer Detection Device Trial Confirms Current Tests Miss Disease</title>
      <description>Results of the FDA pivotal clinical trial for  the LightTouch" Non-invasive Cervical Cancer  Detection Device conducted by Guided  Therapeutics, Inc. (GT), indicated that the  current system for diagnosing cervical disease  missed the same amount of disease as a landmark  study carried out by the National Cancer  Institute (NCI).</description>
      <link>http://www.cancercompass.com/cancer-news/article/32406.htm</link>
      <author>CancerCompass</author>
      <pubDate>Sat, 14 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Endocyte Presents Data On EC145 In Treatment Of Ovarian Cancer</title>
      <description>Endocyte, Inc., a cancer drug discovery and  development company, presented data from a Phase  2a clinical trial for EC145, currently in  development as a potential treatment for  advanced ovarian cancer.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32407.htm</link>
      <author>CancerCompass</author>
      <pubDate>Sat, 14 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>New Findings From Northwestern University Describe Advances In Ovarian Cancer</title>
      <description>According to a study from the United States,  About half of unaffected BRCA1/2 carriers have a  negative family history, confounding efforts  toward presymptomatic carrier identification.  Ovarian cancer is preventable for known carriers  but is otherwise highly lethal.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32408.htm</link>
      <author>CancerCompass</author>
      <pubDate>Sat, 14 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Researchers From Harvard University Report Recent Findings In Cancer</title>
      <description>Several components of the Writ signaling cascade  have been shown to function either as tumor  suppressor proteins or as oncogenes in multiple  human cancers, underscoring the relevance of  this pathway in oncogenesis and the need for  further investigation of Wnt signaling  components as potential targets for cancer  therapy.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32411.htm</link>
      <author>CancerCompass</author>
      <pubDate>Sat, 14 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Research On Brain Metastasis Detailed By Scientists At University Of Pittsburgh</title>
      <description>According to recent research from the United  States, Radiosurgery for brain metastasis fails  in some patients, who require further surgical  care. In this paper the authors' goal was to  evaluate prognostic factors that correlate with  the survival of patients who require a resection  of a brain metastasis after stereotactic  radiosurgery (SRS).</description>
      <link>http://www.cancercompass.com/cancer-news/article/32433.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 17 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>NCCN Receives Research Grant To Evaluate Pralatrexate In Solid Tumors And Hematologic Malignancies</title>
      <description>NCCN recently received a research grant from  Allos Therapeutics, Inc. to evaluate the role of  pralatrexate in the treatment of select  hematologic malignancies and solid tumors.  Pralatrexate is the only agent currently  approved by the FDA to treat patients with  relapsed or refractory peripheral T-cell  lymphoma. Investigators from NCCN Member  Institutions are eligible to apply for the  research funding.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32382.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 10 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Study Offers More Evidence To Green Tea's Anti-Cancer Effect</title>
      <description>A new U.S. study has shown that green tea may  help reduce the risk of oral cancer, although  scientists are reluctant to officially endorse  green tea as an effective way of cancer  prevention.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32387.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 10 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Antipsychotic Drugs Fight Cancer</title>
      <description>Drugs used to treat psychiatric disorders are  highly effective at killing cancer cells,  opening up potential new lines of treatments. Dr  Louise Lurze-Mann of the University of NSW  School of Biotechnology and Biomolecular  Sciences was talking with psychiatric  researchers at the University of Queensland when  they mentioned that people with diseases like  schizophrenia appear to have low rates of  cancer, despite being more inclined to smoke  than the general population.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32367.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Alternative To Pap Test Does Not Appear To Be Better For Detecting Cervical Cancer</title>
      <description>A Dutch study that included nearly 90,000 women  finds that liquid-based cytology, a commonly  used alternative to conventional Pap tests, is  not superior to Pap tests for the detection of  cervical cancer precursors or cancer, according  to a study in the October 28 issue of JAMA.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32359.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Nektar Completes Enrollment In Phase 2 Clinical Trial Evaluating NKTR-102 In Patients With Platinum-Resistant Ovarian Cancer</title>
      <description>Nektar Therapeutics announced that it has  completed enrollment ahead of schedule in its  Phase 2 clinical study of NKTR-102 in platinum- resistant ovarian cancer. NKTR-102 is Nektar's  investigational proprietary compound currently  being evaluated in Phase 2 clinical development  in ovarian, breast and colorectal cancers.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32360.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Guided Therapeutics Non-Invasive Cervical Cancer Detection Device Trial Confirms Current Tests Miss Disease</title>
      <description>Results of the FDA pivotal clinical trial for  the LightTouch(TM) Non-invasive Cervical Cancer  Detection Device conducted by Guided  Therapeutics, Inc. (GT), indicated that the  current system for diagnosing cervical disease  missed the same amount of disease as a landmark  study carried out by the National Cancer  Institute (NCI).</description>
      <link>http://www.cancercompass.com/cancer-news/article/32362.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Sweet Potatoes Make For A Hearty Soup Base</title>
      <description>It's a safe bet to presume there are soup recipes in today's column because it's colder, furnaces are running and it just seems like a fall thing to do. </description>
      <link>http://www.cancercompass.com/cancer-news/article/32365.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Newly Found Molecule Disrupts Cancer Cells</title>
      <description>U.S. scientists say they have discovered a small  molecule that inhibits the actions of a protein  cancer cells require for survival. The  researchers said they determined the molecule,  called PES, inhibits a type of protein called a  heat-shock protein that helps cells survive  heat, lack of nutrients and other cell-damaging  conditions.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32368.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Alternatively Spliced Tissue Factor Identified As Promising New Biomarker For Aggressive Cancers</title>
      <description>A recently discovered form of the protein that  triggers blood clotting may play a key role in  the molecular mechanisms leading to the growth  of certain metastatic cancers, according to new  research reported by an international team of  scientists.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32371.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Stuffed Acorn Squash Makes A Hearty Entree</title>
      <description>Mollie Katzen's latest cookbook urges beginners  to take on her challenge with easy recipes, such  as this acorn squash entree. Use plain raw  almonds, not roasted or salted, Katzen writes,  and don't chop them too fine.  You can cook the rice and bake the acorn squash  at the same time.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32356.htm</link>
      <author>CancerCompass</author>
      <pubDate>Wed, 04 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Light Stews Still Hearty: Reduce Fat And Salt In Fall Soups</title>
      <description>If you're watching your weight, soup can be  deceptive. What could be more harmless for lunch  or a light dinner? Not so fast. Depending on the  recipe, some soups are full of cream and cheese,  or sometimes worse, they start with a roux. In  place of cream and butter, add flavor to soup  with lots of vegetables, beef broth and dried  and fresh herbs.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32357.htm</link>
      <author>CancerCompass</author>
      <pubDate>Wed, 04 Nov 2009 00:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>